Clinical Trial Update: Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study evaluating Dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease on donepezil has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED